Cigna Fair Value
CG
The fair market value of CGN.SW stock is 129.28 CHF. Relative to the market price of 0 CHF Cigna is overvalued by 56.8%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Cigna Valuation
The fair value level of 129.28 CHF can be considered as an effective entry point for long-term investors to start investing in CGN.SW stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
CGN.SW stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Cigna Group Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
21.15
2
Median P/E over 5 years
13.79
3
Minimum P/E over 5 years
9.97
4
Earning per share (last 12 months)
10.66 USD
Maximum value
1
x
4
=
198.3 CHF
Fair value
2
x
4
=
129.28 CHF
Minimum value
3
x
4
=
93.45 CHF
Cigna Group price metrics
11.32
Annual return (geometric mean)
33.39
Risk (standard deviation) of returns
β
0.32
Beta (volatility compared to market)